AUTL logo

Autolus Therapeutics (AUTL)

Profile

Full Name

Autolus Therapeutics plc

Ticker Symbol

AUTL

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United Kingdom

IPO

June 22, 2018

Indexes

Not included

Website

http://www.autolus.com

Employees

647

Key Details

Price

$1.44(+7.09%)

Market cap

$381.89M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$10.12M(+496.00% YoY)

Annual EPS

-$0.86(+28.33% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.44
AUTL price is $1.44

30-Day Relative Volume

1.23
AUTL 30-day relative volume is 1.23

Price Performance

Price Today change

+7.09%
AUTL price is up +7.09% today

Price YTD change

-38.94%
AUTL price is down -38.94% since January 1st

Price 1-year change

-70.71%
AUTL price is down -70.71% year-on-year

Price 3-year change

-64.48%
AUTL price is down -64.48% over the past 3 years

Price Range

Price All-time high

$53.24
AUTL price is currently -97.30% below its historical high of $53.24

Price 3-year low

$1.10
AUTL price is currently +29.86% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$381.89M
AUTL market capitalization is $381.89 million

Market cap 3-year change

+3.98%
AUTL market capitalization is up +3.98% over the past 3 years

Market cap All-time high

$1.93B
AUTL market capitalization is currently -80.19% below its historical high of $1.93 billion

Market cap sector rank

65.54%
AUTL market capitalization is higher than 65.54% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.08%
AUTL shares outstanding is up +0.08% year-on-year

Shares Outstanding 3-Year Change

+192.75%
AUTL shares outstanding is up +192.75% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.08
AUTL beta is 1.08

200-day SMA

$3.07
AUTL price is currently -53.22% below its 200-day simple moving average

50-day SMA

$1.77
AUTL price is currently -19.07% below its 50-day simple moving average

RSI

39.85
AUTL 14-day relative strength index is 39.85

Volume

1.23
AUTL 30-day relative volume is 1.23

ATR

$0.16
AUTL average true range is $0.16

10-day Historical Volatility

156.24%
AUTL 10-day historical volatility is 156.24%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$10.12M
AUTL annual revenue is $10.12 million

Revenue Analysts estimate

$35.55M
AUTL annual revenue is currently -71.53% lower than the consensus analysts' forecast

Revenue 1-year change

+496%
AUTL annual revenue is up +496% year-on-year

Revenue Sector rank

28.56%
AUTL annual revenue is higher than 28.56% of companies in Healthcare sector

EPS

EPS

-$0.86
AUTL annual earnings per share is -$0.86

EPS Analysts estimate

-$0.91
AUTL annual earnings per share is currently -5.90% lower than the consensus analysts' forecast

EPS 1-year change

+28.33%
AUTL annual earnings per share is up +28.33% year-on-year

EPS Sector rank

60.05%
AUTL annual earnings per share is higher than 60.05% of companies in Healthcare sector

Profit

Gross profit

-$1.27M
AUTL annual gross profit is -$1.27 million

Gross margin

-12.52%
AUTL annual gross profit margin is -12.52%

Operating profit

-$240.79M
AUTL annual operating income is -$240.79 million

Operating margin

-2379.34%
AUTL annual operating profit margin is -2379.34%

Net income

-$220.66M
AUTL annual net profit is -$220.66 million

Net margin

-2180.45%
AUTL annual net profit margin is -2180.45%

Expenses

Total expenses

$250.91M
AUTL annual total expenses is $250.91 million

Operating expenses

$239.52M
AUTL annual total operating expenses is $239.52 million

Cost of goods sold

$11.39M
AUTL annual cost of goods sold is $11.39 million

Selling, general & administrative expenses

$101.09M
AUTL annual SGA is $101.09 million

Depreciation and amortization

$7.72M
AUTL annual depreciation & amortization is $7.72 million

Interest expense

$9.29M
AUTL annual interest expense is $9.29 million

Income tax

$1.53M
AUTL annual income tax is $1.53 million

EBIT & EBITDA

EBIT

-$209.84M
AUTL annual earnings before interest & taxes is -$209.84 million

EBITDA

-$202.12M
AUTL annual EBITDA is -$202.12 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$782.73M
AUTL annual total assets is $782.73 million

Non current assets

$121.80M
AUTL annual long term assets is $121.80 million

Current assets

$660.93M
AUTL annual total current assets is $660.93 million

Cash and cash equivalents

$227.38M
AUTL annual cash & cash equivalents is $227.38 million

Accounts receivable

$15.00K
AUTL annual accounts receivable is $15.00 thousand

Inventory

$4.14M
AUTL annual inventory is $4.14 million

Liabilities

Total liabilities

$355.40M
AUTL annual total liabilities is $355.40 million

Long term liabilities

$294.66M
AUTL annual total long term liabilities is $294.66 million

Current liabilities

$60.74M
AUTL annual total current liabilities is $60.74 million

Accounts payable

$1.97M
AUTL annual accounts payable is $1.97 million

Debt

Total debt

$52.63M
AUTL annual total debt is $52.63 million

Total debt 1-year change

-0.64%
AUTL annual total debt is down -0.64% year-on-year

Long term debt

$49.63M
AUTL annual long term debt is $49.63 million

Short term debt

$3.00M
AUTL annual short term debt is $3.00 million

Equity & Capital

Shareholders equity

$427.32M
AUTL annual stockholders equity is $427.32 million

Book value

$427.32M
AUTL annual book value is $427.32 million

Retained earnings

-$1.10B
AUTL annual retained earnings is -$1.10 billion

Working capital

$600.19M
AUTL annual working capital is $600.19 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$206.27M
AUTL annual cash flow from operations is -$206.27 million

Cash from operations 1-year change

-41.68%
AUTL annual cash flow from operations is down -41.68% year-on-year

Cash from investing

-$394.55M
AUTL annual cash flow from investing activities is -$394.55 million

Cash from investing 1-year change

-3491.41%
AUTL annual cash flow from investing activities is down -3491.41% year-on-year

Cash from financing

$589.55M
AUTL annual cash flow from financing activities is $589.55 million

Cash from financing 1-year change

+66867.16%
AUTL annual cash flow from financing activities is up +66867.16% year-on-year

CAPEX

CAPEX

$34.82M
AUTL annual capital expenditures is $34.82 million

CAPEX 1-year change

+216.94%
AUTL annual capital expenditures is up +216.94% year-on-year

Free Cash Flow

Free cash flow

-$241.09M
AUTL annual free cash flow is -$241.09 million

Free cash flow 1-year change

-53.98%
AUTL annual free cash flow is down -53.98% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-12.52%
AUTL annual gross profit margin is -12.52%

Operating margin

-2379.34%
AUTL annual operating profit margin is -2379.34%

Net margin

-2180.45%
AUTL annual net profit margin is -2180.45%

ROA & ROE

ROA

-38.11%
AUTL annual return on assets is -38.11%

ROE

-81.91%
AUTL annual return on equity is -81.91%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
AUTL price to earnings ratio value is unknown

PE ratio Sector rank

-
AUTL price to earnings ratio is unknown

PB Ratio

PB ratio

0.89
AUTL price to book ratio is 0.89

PB ratio Sector rank

41.32%
AUTL price to book ratio is higher than 41.32% of companies in Healthcare sector

PS Ratio

PS ratio

37.74
AUTL price to sales ratio is 37.74

PS ratio Sector rank

90.13%
AUTL price to sales ratio is higher than 90.13% of companies in Healthcare sector

Enterprise value

Enterprise value

$207.14M
AUTL enterprise value is $207.14 million

Enterprise value Sector rank

59.42%
AUTL enterprise value is higher than 59.42% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.02
AUTL EV/EBITDA is -1.02

EV/EBITDA Sector rank

42.78%
AUTL EV/EBITDA is higher than 42.78% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

10.88
AUTL annual current ratio is 10.88

Quick ratio

10.81
AUTL annual quick ratio is 10.81

Leverage

Debt to equity

0.00
AUTL annual debt to equity ratio is 0.00

Interest coverage ratio

-22.58
AUTL annual interest coverage ratio is -22.58

Risk & Stability

Piotroski F-Score

-
AUTL piotroski f-score value is unknown

Altman Z-Score

-1.27
AUTL altman z-score is -1.27

Analyst ratings

Recent major analysts updates

Apr 10, 25 Needham
Buy
Apr 1, 25 Truist Securities
Buy
Mar 21, 25 Wells Fargo
Overweight
Jan 13, 25 Needham
Buy
Dec 9, 24 Needham
Buy
Dec 5, 24 Needham
Buy
Nov 18, 24 Goldman Sachs
Buy
Nov 15, 24 Redburn Atlantic
Buy
Nov 13, 24 Needham
Buy
Nov 12, 24 Needham
Buy

Institutional Ownership

Similar stocks

ALT logo
Altimmune (ALT)
CYH logo
Community Health Systems (CYH)
Rapport Therapeutics (RAPP)
TBRG logo
TruBridge (TBRG)
KMDA logo
Kamada (KMDA)
TRML logo
Tourmaline Bio (TRML)
ERAS logo
Erasca (ERAS)
ORIC logo
ORIC Pharmaceuticals (ORIC)
Maze Therapeutics (MAZE)
  • What is the ticker symbol for Autolus Therapeutics?
  • Does Autolus Therapeutics pay dividends?
  • What sector is Autolus Therapeutics in?
  • What industry is Autolus Therapeutics in?
  • What country is Autolus Therapeutics based in?
  • When did Autolus Therapeutics go public?
  • Is Autolus Therapeutics in the S&P 500?
  • Is Autolus Therapeutics in the NASDAQ 100?
  • Is Autolus Therapeutics in the Dow Jones?
  • When was Autolus Therapeutics's last earnings report?
  • When does Autolus Therapeutics report earnings?
  • Should I buy Autolus Therapeutics stock now?

What is the ticker symbol for Autolus Therapeutics?

The ticker symbol for Autolus Therapeutics is NASDAQ:AUTL

Does Autolus Therapeutics pay dividends?

No, Autolus Therapeutics does not pay dividends

What sector is Autolus Therapeutics in?

Autolus Therapeutics is in the Healthcare sector

What industry is Autolus Therapeutics in?

Autolus Therapeutics is in the Biotechnology industry

What country is Autolus Therapeutics based in?

Autolus Therapeutics is headquartered in United Kingdom

When did Autolus Therapeutics go public?

Autolus Therapeutics's initial public offering (IPO) was on June 22, 2018

Is Autolus Therapeutics in the S&P 500?

No, Autolus Therapeutics is not included in the S&P 500 index

Is Autolus Therapeutics in the NASDAQ 100?

No, Autolus Therapeutics is not included in the NASDAQ 100 index

Is Autolus Therapeutics in the Dow Jones?

No, Autolus Therapeutics is not included in the Dow Jones index

When was Autolus Therapeutics's last earnings report?

Autolus Therapeutics's most recent earnings report was on Mar 20, 2025

When does Autolus Therapeutics report earnings?

The next expected earnings date for Autolus Therapeutics is May 14, 2025

Should I buy Autolus Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page